LIGAND PHARMACEUTICALS INCORPORATED Form D Notices of Exempt Offering of Securities
Notices filed with the SEC for securities sold without registration under Regulation D or Section 4(a)(5), newest first. Values are as filed.
- 2016-01-25: Federal exemption Rule 506(c); Types of securities offered Equity; Date of first sale 2016-01-08; Total offering amount $85,438,489.
| Filed | Federal exemption | Types of securities offered | Date of first sale | Total offering amount | Total amount sold | Total remaining to be sold | Investors who have already invested |
|---|---|---|---|---|---|---|---|
| 2016-01-25 | Rule 506(c) | Equity | 2016-01-08 | $85,438,489 | $85,438,488 | $1 | 22 |